A portion of amino acids 801-829 from the human protein was used as the immunogen for this LRIG1 antibody.
LRIG1 act as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation.
